-
1دورية أكاديمية
المؤلفون: Matt G. Sorrells, Yurim Seo, Melia Magnen, Bliss Broussard, Roya Sheybani, Ajay M. Shah, Hollis R. O’Neal, Henry T. K. Tse, Mark R. Looney, Dino Di Carlo
المصدر: Diagnostics, Vol 13, Iss 8, p 1435 (2023)
مصطلحات موضوعية: sepsis, neutrophil extracellular traps, sepsis diagnostics, neutrophil, monocyte, novel biomarkers, Medicine (General), R5-920
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Colin Valet, Mélia Magnen, Longhui Qiu, Simon J. Cleary, Kristin M. Wang, Serena Ranucci, Elodie Grockowiak, Rafik Boudra, Catharina Conrad, Yurim Seo, Daniel R. Calabrese, John R. Greenland, Andrew D. Leavitt, Emmanuelle Passegué, Simón Méndez-Ferrer, Filip K. Swirski, Mark R. Looney
المصدر: The Journal of Clinical Investigation, Vol 132, Iss 7 (2022)
مصطلحات موضوعية: Hematology, Stem cells, Medicine
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1558-8238
-
3
المؤلفون: Yurim Seo, Longhui Qiu, Mélia Magnen, Catharina Conrad, S. Farshid Moussavi-Harami, Mark R Looney, Simon J Cleary
المصدر: bioRxiv
مصطلحات موضوعية: Article
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9f3b90ff21318f1aaa70cf90aa53232
https://doi.org/10.1101/2023.02.01.526706 -
4
المؤلفون: Eunjoo Pacifici, Yurim Seo
المصدر: Vaccine
مصطلحات موضوعية: Package insert, 030231 tropical medicine, Harmonization, Product Labeling, Article, 03 medical and health sciences, 0302 clinical medicine, EMA, Prescribing information, Cognitive dissonance, media_common.cataloged_instance, Humans, 030212 general & internal medicine, European union, Summary of Product Characteristics, Drug Approval, media_common, Pharmaceutical industry, Drug Labeling, Vaccines, General Veterinary, General Immunology and Microbiology, business.industry, Harmonisation, United States Food and Drug Administration, Public Health, Environmental and Occupational Health, Advertising, Regulatory, United States, Infectious Diseases, Immunisation, Pharmaceutical Preparations, Molecular Medicine, business, FDA